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The aim of our study was to determine the epidemiological and clinical aspects of vitiligo in the largest dermatology department
of Senegal. A cross-sectional and descriptive study in a period of 5 months was performed covering all the vitiligo cases. Fifty
patients were identiﬁed (26 women and 24 men). The mean age was 26.5 years. A family history of vitiligo was found in 11 cases
and a psychoaﬀective disturbance in 6 cases. The clinical forms distinguished were generalized vitiligo (n = 33), localized vitiligo
(n = 16), vitiligo universalis (n = 4), and segmental vitiligo (n = 1). The Koebner phenomenon was found in 7 cases. Associated
diseases were atopic dermatitis (n = 2), contact dermatitis (n = 1), diabetes (n = 1), and Graves’ disease (n = 1). The disgraceful
character of Vitiligo was the predominance of generalized forms and the elective localization in sun-exposed areas. The family




functional melanocytes or by the decrease of melanin in the
epidermis. Its prevalence is about 0.1 to 2% depending on
the country [1]. Although asymptomatic and non-disabling,
vitiligo is a very debilitating disease because of its exhibited
and highly unpleasant character on dark skin. Nowadays,
no pathophysiological mechanism has been yet elucidated.
Antibodies against melanocytes and free radicals aﬀecting
cell membranes or cytoplasmic components have been
suspected till today [2–4]. There is no eﬃcient treatment.
Due to its benignity, very few studies have been devoted to
this disease in Africa and none in Senegal. The aim of our
study was to report the epidemiological and clinical aspects
of vitiligo in Senegal.
2. Patientsand Methods
We conducted a cross-sectional and descriptive study, iden-
tifying all the cases of vitiligo seen over a period of ﬁve
months in the dermatology department of the university
teaching hospital Le Dantec. It is the largest referral center of
dermatology in Dakar, the capital of Senegal. The diagnosis
of vitiligo was based on clinical and histological data. The
examination searched for the family history of vitiligo, a
psychoaﬀective shock in the 3 years preceding the onset
of lesions and a Koebner phenomenon. It also searched
for another associated autoimmune disease such as type I
diabetes, Graves’ disease, and autoimmune thyroiditis.
3. Results
Out of 4192 patients seen during this period, 50 presented a
vitiligo corresponding to a frequency of 1.2% among them
26 women (52%) and 24 men with a sex ratio of 0.9. The
mean age of the lesion’s inception was 26.5 years, ranging
from 15 days to 66 years. Patients under 20 years were 21
(42%). A family history of vitiligo (Figure 1)w a sn o t e d
in 11 cases (22%). Among them, one was a homozygote
twin. A psychoaﬀective disturbance was noted in the patients
aged over 18 years old in 6/37 cases (16.2%) in the 3 years
preceding the onset of the lesions. It was mourning in 3
cases, a job loss, a pregnancy, or a change of residence each2 ISRN Dermatology
Figure 1: Generalized vitiligo of a two years old children (a family
history vitiligo).
Figure 2: Localized vitiligo.
in 1 case. The clinical presentation was a generalized vitiligo
aﬀectingmorethanoneregionofthebodyin33cases(66%),
a localized vitiligo (Figure 2) in 16 cases (32%), a vitiligo
universalis in 4 cases (8%) and a segmental vitiligo localized
in a dermatome in 1 case (2%) (Table 1). The Koebner
phenomenon was found in 7 cases (14%). The distribution
of the cases according to the topography is illustrated in
Table 2. Other associated troubles were type I diabetes in 1
case, contact dermatitis in 3 cases, lichen planus in 2 cases,
maniac depressive disorder in 1 case.
4. Discussion
We report 50 cases of vitiligo observed over a period of
5 months. The characteristics of our study are the pre-
dominance of the generalized form, the rarity of the seg-
mental form, the elective topography in sun-exposed areas,
the existence of a Koebner phenomenon, and an anterior
psychoaﬀective shock in about a quarter of cases each. Our
study was limited by its short duration which did not allow
ustoevaluatethelesions’outcomeonthelongrun.The1.2%
frequency is close to the one registered by Sehgal et al. in
Table 1: Diﬀerent clinical forms of vitiligo.
Clinical forms Patients %
Generalized vitiligo 33 66%
Localised vitiligo 16 32%
Vitiligo universalis 4 8 %
Segmental vitiligo 1 2%
Table 2: Distribution lesions of vitiligo.
Localization of lesions Patients %
Sun-exposed areas 37 61%
Limbs 16 26%
Trunk 14 23%
Genital area region 11 18%
Hair 15 25%
India [5] and the frequency of 1 to 2% reported worldwide
[6]. The female predominance was also observed by Kar
[7] who noted 51.6% of women against 48.35% of men.
Boisseau-Garsaud et al. [8] then explained this diﬀerence by
a greater concern for aesthetics in women who consult more.
The onset mean of our patients was 26.5 years, close to the
one of 29 years noted by Boisseau-Garsaud et al. [8]. This
distribution is consistent with the usual data that locates the
onset age of vitiligo between 10 and 30 years. The congenital
vitiligo observed in our study is unusual in the western series
[6].Itsfrequencymaybeunderestimatedduetothediﬃculty
of identiﬁcation on the Caucasian newborn skin.
The existence in our study of vitiligo in another family
member (22%) and even in a homozygous twin highlights
the genetic predisposition of this disease. Besides, Mosher
and Jaigirdar have observed it, respectively, in 21% and 24%
[6,9].Indeed,amutationinthegeneNAPL1(Nachtleucine-
rich-repeat protein 1) has been identiﬁed as correlated
with the risk of developing vitiligo [10]. The concept of
sustainable stress noted in the past medical history is present
in all the patients of Papadopoulos’s series [11, 12]w h o
found economic diﬃculties in 35% of cases, mourning in
42.5% of cases, a diﬃcult pregnancy in 16% cases and
a change of residence in 26% of cases. Koebner’s phe-
nomenon was objectiﬁed in the studies of Gauthier [13]a n d
Jaigirdar et al. [9] in 30% and 100% of cases. Maria et al.
[14] noted in her comparative series a Koebner phenomenon
in 66.2% of the bilateral vitiligo and 44.4% in the unilateral
type of vitiligo. In itching dermatosis such as eczema
and lichen planus, the scratching lesions act by Koebner’s
phenomenon. Some daily gestures such as friction with the
bath glove in African can be aggravating factors. The rate
of diﬀerent clinical forms varies depending on the series.
Our results are superposed to those of Martis [15]w h i c h
found 65% of generalized forms, 32% of localized forms,
and 3% of segmental forms. They are diﬀerent from those
of Handa and Kaur [16] who found in his series of 1436
cases diﬀused lesions in 69.8% and only 14.9% of localized
forms [11, 15]. The elective topography in sun-exposed
areas was also observed by Kar [17]. According to someISRN Dermatology 3
authors, the sun would act by a Koebner phenomenon [6,
15].Thepalmoplantarlocalizationsandmucousmembranes
(vulva, lips) seem more frequent in patients with racial
pigmentation [6, 15]. Nevertheless, labial involvement may
be overestimated because of the frequent confusion with
other postinﬂammatory cheilitis. The association with other
autoimmune diseases reported elsewhere was infrequent in
our study. Only one case of type II diabetes and one case of
Graves’ disease were identiﬁed in our series.
5. Conclusion
Thedisplaying characterofvitiligoin ourstudyevidencedby
the predominance of generalized forms, elective topography
in the sun-exposed areas, and the majority involvement in
women focuses more on aesthetic prejudice induced on dark
skin.
The development of better treatment protocols is neces-
sary.
References
[1] J. J. Nordlund, “The epidemiology and genetics of vitiligo,”
Clinics in Dermatology, vol. 15, no. 6, pp. 875–878, 1997.
[2] E. H. Kemp, E. A. Waterman, and A. P. Weetman, “Autoim-
muneaspectsofvitiligo,”Autoimmunity,v ol.34,no .1,p p .65–
77, 2001.
[ 3 ]W .J .C u n l i ﬀe ,R .H a l l ,D .J .N e w e l l ,a n dC .J .S t e v e n s o n ,
“Vitiligo, thyroid disease and autoimmunity,” British Journal
of Dermatology, vol. 80, no. 3, pp. 135–139, 1968.
[4] C. Betterle, A. Caretto, and A. De Zio, “Incidence and
signiﬁcance of organ-speciﬁc autoimmune disorders (clinical,
latent or only autoantibodies) in patients with vitiligo,” Der-
matologica, vol. 171, no. 6, pp. 419–423, 1985.
[5] V. N. Sehgal, V. L. Rege, and F. Mascarenhas, “Clinical patern
of vitiligo amongst Indian,” TheJournalofDermatology, vol. 3,
pp. 49–53, 1976.
[6] D. B. Mosher, T. B. Fitzpatrick, Y. Hori, and J. P. Ortonne,
“Disorders of pigmentation,” in Dermatologie in General
Medecine,T .B .F i t z p a t r i c k ,A .E i s e n ,a n dK .W o l ﬀ, Eds., pp.
903–995, Macgrow-Hill, New York, NY, USA, 1993.
[ 7 ]P .K .K a r ,“ V i t i l i g o :as t u d yo f1 2 0c a s e s , ”Indian Journal of
Dermatology, vol. 67, pp. 302–304, 2001.
[8] A. M. Boisseau-Garsaud, P. Garsaud, D. Cal` es-Quist, R.
H´ el´ enon, C. Qu´ en´ eherv´ e, and R. C. S. Claire, “Epidemiology
of vitiligo in the French West Indies (Isle of Martinique),”
International Journal of Dermatology, vol. 39, no. 1, pp. 18–20,
2000.
[9] M. Q. Jaigirdar, S. M. Alam, and A. Z. Maidul, “Clinical pre-
sentation of vitiligo,” Mymensingh Medical Journal, vol. 11, no.
2, pp. 79–81, 2002.
[10] Y. Jin, C. M. Mailloux, K. Gowan et al., “NALP1 in vitiligo-
associated multiple autoimmune disease,” New England Jour-
nal of Medicine, vol. 356, no. 12, pp. 1216–1225, 2007.
[11] L. Papadopoulos, R. Bor, and C. Legg, “Coping with the
disﬁguring eﬀects of vitiligo: a preliminary investigation into
the eﬀects of cognitive-behavioural therapy,” British Journal of
Medical Psychology, vol. 72, no. 3, pp. 385–396, 1999.
[ 1 2 ] L .P a p a d o p o u l o s ,R .B o r ,C .L e g g ,a n dJ .L .M .H a w k ,“ I m p a c t
of life events on the onset of vitiligo in adults: preliminary
evidence for a psychological dimension in aetiology,” Clinical
and Experimental Dermatology, vol. 23, no. 6, pp. 243–248,
1998.
[13] Y. Gauthier, “The importance of Koebner’s phenomenon in
the induction of vitiligo vulgaris lesions,” European Journal of
Dermatology, vol. 5, no. 8, pp. 704–708, 1995.
[14] I. Maria, M. D. Barona, and A. Adriana, “An epidemiologic
case-control study in a population with vitiligo,” Journal of the
American Academy of Dermatology, vol. 33, pp. 625–655, 1995.
[15] J. P. Ortonne and E. Grosshans, “Les troubles de la pig-
mentation cutan´ ee,” in Dermatologie et Maladies Sexuellement
Transmissibles, J. H. Saurat, E. Grosshans, P. Laugier, and J.M.
Lachapelle, Eds., pp. 407–426, Masson, Paris, France, 1999.
[16] S. Handa and I. Kaur, “Vitiligo: clinical ﬁndings in 1436
patients,” Journal of Dermatology, vol. 26, no. 10, pp. 653–657,
1999.
[17] P. K. Kar, “Vitiligo : a study of 120 cases,” Indian Journal of
Dermatology, Venereology and Leprology, vol. 67, pp. 302–304,
2001.